Equity - Narrative (Details)	9 Months Ended		12 Months Ended
	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($) shares	Dec. 31, 2021 USD ($) $ / shares shares	Aug. 31, 2022 shares
Equity [Line Items]
Authorized amount (in shares)				10,000,000
Stock repurchased and retired during period (in shares)	11,702,074
Stock repurchased and retired during period (in dollars per share) | $ / shares	$ 10.84
Common shares repurchased (in shares)		0
Shares remaining available for repurchase (in shares)	7,274,241
Unsettled repurchases | $	$ 3,649,000
Series C cumulative convertible preferred, shares outstanding (in shares)	1,935,400		1,935,400
Series C cumulative convertible preferred, liquidation preference | $	$ 96,770,000		$ 96,770,000
OP unit equivalent in common shares	1.13
Partners' capital account (in units)	745,000
Series C Cumulative Convertible Preferred Stock
Equity [Line Items]
Series C cumulative convertible preferred, shares outstanding (in shares)	1,935,400
Preferred stock, dividend per annum (in dollars per share) | $ / shares	$ 3.25
Series C cumulative convertible preferred, liquidation preference | $	$ 96,770,000
Convertible preferred stock, conversion ratio	2.4339
Preferred stock conversion, threshold conversion price percentage (at least)	1.25
Forward Contracts
Equity [Line Items]
Number of shares sold (in shares)	3,649,023	3,875,751
Proceeds from sale of stock | $	$ 38,492,000	$ 41,933,000
Share-based Payment Arrangement
Equity [Line Items]
Shares granted (in shares)	47,505	38,803
Grant date fair value | $	$ 616,000	$ 437,000
At-The-Market Program
Equity [Line Items]
Number of shares sold (in shares)		1,052,800
Proceeds from sale of stock | $		$ 13,574,000
Sale of stock, authorized amount (up to) | $			$ 350,000,000
Common shares amount available for issuance | $	294,985,000
Underwritten Offering | Forward Contracts
Equity [Line Items]
Number of shares to be settled on a forward basis (in shares)			16,000,000
Sale of stock (in dollars per share) | $ / shares			$ 12.11
Shares to be settled on forward basis, aggregate value | $	$ 182,141,000